or
Bookmark and Share
POLYANIONIC COMPOUNDS IN CULTURE MEDIA
   
Document Number
US Patent 3671399
Issued Date
June 20, 1972
Link
Inventors
Evans; George (Hopatcong, NJ)
Searcy; Ronald (Upper Montclair, NJ)
Map
Abstract
Sulfated polysaccharide, polyethylene sulfonic acid, polyvinyl sulfuric acid, polystyreme sulfonic acid, a sulfate ester of a polyethylene ether of an aliphatic alcohol having from 12 to 18 carbon atoms, monothioglycerol or sulfated naphthalene are combined with a bacterial culture medium. These compositions inhibit the antibacterial components of contaminated body fluids, thereby allowing the contaminant bacteria to grow freely.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
22
Comments:
no comments yet
Owner
Published
June 20, 1972
Application Number
04/756,427
Filed
August 30, 1968
US Classification
435/34   435/252.1 435/252.8 435/253.4 435/800
Int'l Classification
C12Q   1/04   (20060101)  
Assistant Examiner
Parent Case
RELATED APPLICATIONS This application is a continuation-in-part of U.S. patent application Ser. No. 697,585, filed Jan. 15, 1968 now abandoned.
USPTO Field of Search
697/585   424/180   195/103.5   195/100   195/114   195/28R   195/29  
Related Patents
4340679 - Culture media for inactivation of bacterial growth inhibitors - Owned by Abbott Laboratories (North Chicago, IL)

This invention encompasses methods and reagents for inactivation of bacterial growth inhibitors present in blood, serum or plasma. It has been found that salicylates and closely related compounds will neutralize bacterial growth inhibitors present in the blood of many patients. The addition of salicylate to conventional growth medium also provides a reagent for monitoring the antibiotic levels in blood by enabling measurement of the effect of the antibiotic against a standard test organism without interference from the bacterial growth inhibitor present in sera.

4483926 - Method for measuring antibiotic levels in blood serum - Owned by Abbott Laboratories (North Chicago, IL)

This invention encompasses methods and reagents for inactivation of bacterial growth inhibitors present in blood, serum or plasma. It has been found that salicylates and closely related compounds will neutralize bacterial growth inhibitors present in the blood of many patients. The addition of salicylate to conventional growth medium also provides a reagent for monitoring the antibiotic levels in blood by enabling measurement of the effect of the antibiotic against a standard test organism without interference from the bacterial growth inhibitor present in sera.

4602007 - Salicylate culture media for inactivation of bacterial growth inhibitors - Owned by Abbott Laboratories (North Chicago, IL)

This invention encompasses methods and reagents for inactivation of bacterial growth inhibitors present in blood, serum or plasma. It has been found that salicylates and closely related compounds will neutralize bacterial growth inhibitors present in the blood of many patients. The addition of salicylate to conventional growth medium also provides a reagent for monitoring the antibiotic levels in blood by enabling measurement of the effect of the antibiotic against a standard test organism without interference from the bacterial growth inhibitor present in sera.

4330622 - Elimination of non-microbial turbidity in culture media - Owned by Becton Dickinson & Co. (Paramus, NJ)

In the culturing of micro-organisms, non-microbial turbidity in the supernate is prevented by including an adsorbant for components which cause such non-microbial turbidity; e.g., lipoproteins and/or chylomicrons, with such adsorbant being soluble in the culture media. The adsorbant sediments such components, and is particularly effective in culture media which include an anticoagulant. Carboxy Methyl Cellulose is a particularly effective adsorbant.

5501960 - Method for improving quantitative recovery of microorganisms from specimens containing blood components

A method for increasing the quantitation of microorganisms in cell-containing or cell-free blood samples, included those intended for blood product transfusion purposes, is provided which employs a sustained level of sodium polyanethol sulfonate throughout microbial replication on solid media. In another embodiment, purified saponin is combined with sodium polyanethol sulfonate to provide increased quantitation of microorganisms.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us